Synthelis protein catalog now available on Biocompare!

Synthelis is pleased to announce that its protein catalog is now available on the life science product platform Biocompare.Access the full list here.

NEW Application Note from Synthelis! “Label-free Kinetic Analysis of Membrane Protein Interactions Using Biolayer Interferometry (BLI)”

In this application note, Synthelis demonstrates the determination of interaction between a liposome embedded GPCR protein and specific ligands using the Octet RED96 system (Pall FortéBio). The biolayer interferometry (BLI) monitors the binding of proteoliposomes to their partners directly in real time to measure physiologically-relevant results closely to native conditions. Synthelis proteoliposomes are therefore adapted [...]

Synthelis will attend the Cambridge Ion Channel Forum, 21 April 2017, Cambridge (UK)

Meet us next week at the Cambridge Ion Channel Forum at Medimmune offices in Cambridge, UK.Feel free to arrange a meeting by contacting us. Our sales manager Safia Ezzine will then be attending the 10th Annual Proteins & Antibodies Congress (24-25 April) in London, so let us know when is the best time to meet. For more information, visit [...]

Join Synthelis now !

We are looking for a project manager for our headquarters in Grenoble, France. Join us now!See job description. Do no hesitate to contact us at job@synthelis.fr.

Synthelis conducts a seminar at Hôpital Cochin on April 5th, 2017 (Paris, France)

Synthelis has been invited to conduct a seminar today at Hôpital Cochin, Paris, France. The seminar will focus on how cell-free system can bring new solutions for the protein production. Sandra Cortès, PhD, Synthelis CSO will then present "Systèmes d’expression « cell-free »: de nouvelles possibilités pour la production de protéines" Please note that this seminar is [...]

NEW! Vaccinia virus major membrane protein (F5L) is now available in our protein catalog

A new receptor is now available in our protein catalog. The major membrane protein F5L is a Variola virus protein required for the virus replication. The other potential functions of this protein are still unknown. Feel free to contact our in-house experts to learn more and discuss how this protein could be relevant to your application. Learn more about F5L. Are [...]

Synthelis will attend the Forum de la Recherche en Cancérologie Auvergne-Rhône-Alpes, 4-5 April 2017, Villeurbanne

Meet us next week at the Forum de la Recherche en Cancérologie Auvergne-Rhône-Alpes in Villeurbanne (France)Feel free to arrange a meeting by contacting us.  For more information, visit the event page.

Synthelis will attend the 10th Annual Proteins & Antibodies Congress, 24-25 April 2017, London (UK)

Meet us in London, UK, at the 10th Annual Proteins & Antibodies Congress!Visit our poster "Cell-free expression as an innovative tool for antigen production" (poster number to be announced shortly) and learn more about how our cell-free technology can support you in your projects.Feel free to arrange a meeting by contacting us. Our sales manager Safia Ezzine will [...]

Join Synthelis now !

We are looking for a lab technician for our headquarters in Grenoble, France. Join us now!See job description. Do no hesitate  to contact us at job@synthelis.fr.

NEW publication! “Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells”

Synthelis’ innovative patented cell-free technology allows customized expression and characterization of active proteins, packaged in proteoliposomes  or delivered in a detergent solution. This makes it particularly suitable for the expression of membrane proteins, which are well known to be challenging to produce in a usable form. The independence of cell-free technology from the physiological constraints of cell-based systems, [...]

Synthelis featured in the French journal Dauphiné Entreprises

Synthelis is featured in this week issue of Dauphiné Entreprises journal.  The article highlights our new distributor agreement with Japanese company Funakoshi Co., Ltd. Funakoshi has then become the first distributor of Synthelis off-the-shelf products in Japan, extending our cell-free technology offer more globally.  Our President Bruno Tillier explains this strategic partnership as well latest news at Synthelis. Read the [...]

NEW High Throughput Multigene Expression services

We are pleased to announce today the launch of our new High Throughput Multigene Expression services! Take advantage of fast and efficient screening for multiple gene expression thanks to Synthelis' cell-free technology and dedicated process.  Obtain fast expression of a large number of DNA constructs and preliminary information available on 384 expression conditions in 24 hours Select rapidly soluble protein samples Take [...]

Synthelis will attend the 10th Symposium of Vaccinology, March 20-21, Paris (France)

Meet us next week in Lyon at the 10th Symposium of Vaccinology!Our CEO Bruno Tillier will be attending the meeting so feel free to arrange a meeting with him by contacting us.  For more information, visit the event page.

SPECIAL OFFER! 50% off Kinurenine 3-monooxygenase (KMO)

Take advantage of this special offer to test cell-free produced KMO(1). This product is available in proteoliposome format and in your desired quantities(2) (10µg, 20µg, 50µg, 100µg, 200µg, 500µg). Source KMO wild type protein (human) Purity >70% Activity Validated by spectrophotometric assay Biological function Synthesis of quinolinic acid Applications Drug target for several neurodegenerative and neuroinflammatory diseases Are [...]

Synthelis services now available on ScienceExchange.com

Synthelis is now referenced on ScienceExchange.com. You can now order our services directly from this platform, giving you the possibility to simplify ordering and legal processes.If you have any question please contact us.

Service highlight: From Gene to Structure Services

Thanks to Synthelis' expertise in cell-free expression technology and key position at the heart of the Grenoble structural biology cluster, obtain the best protein for your application! Obtain functional, labeled and/or pure proteins in large quantities Select the relevant format for your application (detergent, liposome, nanodisc...) Take advantage of state-of-the-art tools from renown Grenoble structural biology cluster Rely on one dedicated project [...]

We are now hiring!

Synthelis is growing and we need to strengthen our Business development team. We are looking for a Business Development Intern (offre de stage, H/F) for our headquarters in Grenoble, France. Join us now! See job description. Do no hesitate  to contact us at job@synthelis.fr.

Looking for a Business Development Intern

Synthelis is looking for a Business Development intern. Send your application to : job@synthelis.fr  

NEW! Relaxin receptor 1 (RXFP1) is now available in our protein catalog.

A new GPCR is now available in our protein catalog. The relaxin/insulin-like family peptide receptor 1 is the cognate receptor for human relaxin-2 in humans. Human RXFP1 also known as LGR7 is located on chromosome 4q32.1 and is known to activate Erk1/2, tyrosine kinase(s), gene transcription, and nitric oxide (NO) signaling and can also interact with [...]

Synthelis off-the-shelf products now available in Japan

Synthelis announced today an agreement with Funakoshi Co. Ltd., research reagents and instruments distributor in the life science fields, for the distribution of its proteins (including ion channels, transporters, GPCRs, enzymes, etc.). Under this agreement Funakoshi becomes the first distributor of Synthelis off-the-shelf products in Japan. Read full press release.